Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Geographic Atrophy (GA) Secondary to Dry Age-related Macular Degeneration (AMD)”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Early research (Phase 1)Study completedNCT04246866
What this trial is testing

First in Human Study to Evaluate the Safety and Tolerability of GEM103 in Geographic Atrophy Secondary to Dry Age Related Macular Degeneration

Who this might be right for
Dry Age-related Macular DegenerationGeographic AtrophyMacular Degeneration+2 more
Gemini Therapeutics, Inc. 12
Testing effectiveness (Phase 2)Looking for participantsNCT07158775
What this trial is testing

Evaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With Geographic Atrophy Secondary to Dry AMD

Who this might be right for
Geographic Atrophy (GA) Secondary to Dry Age-related Macular Degeneration (AMD)
Bionic Sight LLC 40
Not applicableActive Not RecruitingNCT05797896
What this trial is testing

Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study

Who this might be right for
Dry Age-related Macular DegenerationGeographic AtrophyRetinal Disease+4 more
Complement Therapeutics 250
Large-scale testing (Phase 3)Study completedNCT02686658
What this trial is testing

Zimura in Participants With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

Who this might be right for
Geographic AtrophyDry Age-Related Macular Degeneration
IVERIC bio, Inc. 286
Testing effectiveness (Phase 2)Active Not RecruitingNCT05839041
What this trial is testing

A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Geographic Atrophy of the MaculaMacular Degeneration
Aviceda Therapeutics, Inc. 300
Testing effectiveness (Phase 2)Study completedNCT01342926
What this trial is testing

Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration

Who this might be right for
Atrophy, Geographic
GlaxoSmithKline 191
Testing effectiveness (Phase 2)Ended earlyNCT05893537
What this trial is testing

Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD).

Who this might be right for
Age-Related Macular Degeneration
Cognition Therapeutics 100
Not applicableEnded earlyNCT03894020
What this trial is testing

GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)

Who this might be right for
Dry Age-related Macular DegenerationMacular DegenerationRetinal Disease+3 more
Gyroscope Therapeutics Limited 83
Not applicableLooking for participantsNCT07144137
What this trial is testing

A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
Complement Therapeutics 75